Following the discontinuation of its TIL-based cNeT program and closure of the Phase I/IIa CHIRON and THETIS clinical trials, the Company has ...
Cash position of $86.1 million as of September 30, 2024, not including cash R&D tax credit of $12.8 million received in October 2024 - LONDON, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Achilles Therapeutics ...
LONDON, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Achilles Therapeutics plc (NASDAQ: ACHL) today announced its financial results for ...
The Titans collected an overtime win on Sunday, but their offensive line suffered a notable blow in the process. Center Lloyd Cushenberry departed the contest with an ankle injury which now threatens ...
Indiana Pacers center Isaiah Jackson has sustained a torn right Achilles tendon, the team announced Saturday. An MRI earlier Saturday confirmed the tear. Jackson is set to undergo surgery Monday.
Now, that appears to be true. Sources inform Shams Charania of ESPN that Jackson has torn his right Achilles tendon, and will now be out for the rest of the season. He'll undergo surgery to ...
ESSEX, Conn.--(BUSINESS WIRE)--Thetis Pharmaceuticals, LLC (“Thetis”), a clinical-stage company developing TP-317, an oral small molecule therapy based on Resolvin E1 (RvE1) for the treatment ...
ESSEX, Conn.--(BUSINESS WIRE)--#BLT1--Thetis Pharmaceuticals, LLC (“Thetis”), a clinical-stage company developing TP-317, an oral small molecule therapy based on Resolvin E1 (RvE1) for the treatment ...
Speaking to Red Corner MMA after the fight, the Australian MMA star revealed it wasn't his jaw that was the issue, rather, his bottom teeth which have always been his 'Achilles heel'. "I'm alright ...
The cleanup of a Thetis Island property that has been the subject of legal action since 2020 has been authorized by a B.C. Supreme Court order. The executive committee of the Islands Trust ...
It looks like it could be an Achilles tear, so that would be devastating for him and for us. "That's what I’ve been told at the moment. We hope that won’t be the case but I think that’s what ...